YonaLink has announced its EHR-to-EDC data integration platform has been implemented by Hadassah Medical Organization (HMO) in Jerusalem. Hadassah is leveraging YonaLink’s SaaS solution to stream and map up-to-date, real-time patient data directly from EHR to EDCsystems, enabling greater speed, quality, and efficiency in clinical trial data collection.
The partnership with YonaLink is part of Hadassah’s larger focus on driving innovation in medical research and making Hadassah and Israel hubs for global clinical trials across therapeutic areas. Using YonaLink’s technology will enable Hadassah to partner with clinical trial sponsors and research stakeholders around the world and expand access to the medical center’s R&D capabilities.
YonaLink’s platform provides the capabilities to stream up-to-date data from any clinical site’s EHR system, in any part of the world, and populate it within YonaLink’s EDC. With built-in eConsent and ePRO/eCOA and streaming EHR-to-EDC capabilities, YonaLink’s EDC provides a solution for today’s clinical trial needs, bringing EDC and eSource functionality together in a single tool.
Hadassah Selects YonaLink’s EHR-to-EDC Clinical Trial Platform to Securely and Seamlessly Integrate Clinical Care and Research Data. (2023, March 22). Business Wire.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.